Stocks Screener

Search any stock or ticker

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

How This Company Makes Money

Dividend Analysis AJANTPHARM

Max Ratio

69.71

Dividend Yield

2.13 %

5Y Dividend Growth

523.00 %

Consecutive Years

3 years

5Y Average Payout Ratio

29.65 %

Dividend History AJANTPHARM

1 year
3 years
5 years
10 years
15 years
11/21/2021 - 11/28/2021
Forward Annual Dividend Yield 2.13 %
Consecutive Years 3
Forward Annual Dividend 56.00 INR
Consistent Years 4
Dividend CAGR 3Y 104.29 %
Continuous Dividends
Dividend CAGR 5Y 44.18 %
Payout Ratio TTM 35.95 %
Dividend CAGR 10Y 35.10 %
Ex Dividend Date 11/10/2025

The 5 Pillars Formula Checklist

The Five-Pillar Secret Formula Checklist is our simple, proven way to separate strong, lasting businesses from the rest. We look at five key pillars—sales growth, profit growth, Net Income, dividend safety, and debt levels. Together with Financial Score, they tell us if a company can keep growing, stay financially solid, and reliably pay dividends for decades.

Sales Growth AJANTPHARM

Sales Growth – The Foundation of a Strong Business. Consistent revenue growth over the past 10-15 years is a key sign of a thriving company. It shows that demand for its products and services is increasing, allowing it to expand operations, gain market share, and invest in future growth.
1 year
3 years
5 years
10 years

Profit Growth / Profit Margin AJANTPHARM

The Fuel for Company Growth. Revenue alone isn’t enough—what truly matters is how efficiently a company turns that revenue into consistent, growing profits. Profitability is the foundation of sustainable growth and long-term financial strength.
1 year
3 years
5 years
10 years

Net Income AJANTPHARM

The True Measure of Financial Strength. Net income is what remains after all expenses, taxes, and costs. This is the company’s real earning power.
1 year
3 years
5 years
10 years

Payout Ratio TTM AJANTPHARM

Dividend Payout Safety – Protecting Your Passive Income. A high dividend yield is meaningless if the company can’t afford to sustain it. We evaluate payout ratios to ensure the company is not overextending itself. The best companies have a balanced approach—paying generous dividends while still reinvesting in future growth. Dividend safety is crucial for long-term income stability.
1 year
3 years
5 years
10 years
15 years
11/21/2021 - 11/28/2021

Debt Ratio AJANTPHARM

Debt Burden – Avoiding Financial Traps. Too much debt can cripple a company, even if its revenues and profits look great. We analyze how well a company manages its liabilities, ensuring that debt levels are under control.
1 year
3 years
5 years
10 years
11/21/2021 - 11/28/2021

Full Financial Performance

See how the company makes money over time—revenue, profits, dividends, and more. The charts on the right give you a quick view of growth trends so you can instantly spot consistency or red flags.

Ajanta Pharma Limited AJANTPHARM

1 year
3 years
5 years
10 years
Results 2019 Dynamics
* The data for this period has not yet been published

Bottom Line

Valuation Check

Shows if a stock is priced fairly by looking at peers and the company’s own history — a quick way to see if it’s a bargain or overpriced.

Value vs Peers

The company is measured against at least 10 rivals in the same sector. If it earns 25% more profit per share than the average, it’s Undervalued. If it earns 25% less, it’s Overvalued. In short: stronger earnings per share mean you’re getting a bargain, weaker ones mean you’re overpaying.

Value vs Itself AJANTPHARM

P/E shows how many dollars investors pay in the stock price for each $1 of profit the company earns per share. Today’s P/E is compared with the company’s 10-year average. If the ratio is above that norm, you’re paying up for each dollar of profit. If it’s below, you’re getting more earnings for less.
1 year
3 years
5 years
10 years
11/21/2021 - 11/28/2021
Trailing PE 33.72
Forward PE 27.55
Enterprise Value Revenue 6.48
Price Sales TTM 6.61
Enterprise Value EBITDA 22.25
Price Book MRQ 7.55

Ajanta Pharma Limited Dividends: 2.13 % Yield, History, Payment Schedule

AJANTPHARM
Current price
2 628.50 INR +46.38 INR (+1.80%)
Last closed 2 606.70 INR
ISIN INE031B01049
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
Exchange National Stock Exchange of India
Capitalization 329 060 886 099 INR
Yield for 12 month -9.81 %
1Y
3Y
5Y
10Y
15Y
AJANTPHARM
11/21/2021 - 11/28/2021

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Advanced Highlights

Current Year

+46 559 045 362 INR

Last Year

+42 157 767 634 INR

Current Quarter

+13 560 030 258 INR

Last Quarter

+13 048 372 567 INR

Current Year

+35 833 466 437 INR

Last Year

+30 985 840 479 INR

Current Quarter

+6 780 766 391 INR

Last Quarter

+10 284 940 285 INR
EBITDA 13 405 971 786 INR
Operating Margin TTM 24.07 %
Price to Earnings 33.72
Return On Assets TTM 14.32 %
PEG Ratio
Return On Equity TTM 24.37 %
Wall Street Target Price 268 809.69 INR
Revenue TTM 49 812 699 464 INR
Book Value 346.03 INR
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY 14.10 %
Dividend Yield 2.13 %
Gross Profit TTM 37 731 948 944 INR
Earnings per share 78.07 INR
Diluted Eps TTM 78.07 INR
Most Recent Quarter III 2025
Quarterly Earnings Growth YOY 20.60 %
Profit Margin 19.58 %

Technical Indicators AJANTPHARM

For 52 Weeks

2 305.35 INR 3 086.51 INR
50 Day MA 2 486.15 INR
Shares Short Prior Month
200 Day MA 2 582.96 INR
Short Ratio
Shares Short
Short Percent